Provided by Tiger Trade Technology Pte. Ltd.

Compass Therapeutics, Inc.

5.37
+0.04500.85%
Volume:1.17M
Turnover:6.17M
Market Cap:966.17M
PE:-12.72
High:5.40
Open:5.27
Low:5.19
Close:5.32
52wk High:6.88
52wk Low:1.33
Shares:180.09M
Float Shares:119.00M
Volume Ratio:0.81
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4216
EPS(LYR):-0.4216
ROE:-41.29%
ROA:-25.29%
PB:4.91
PE(LYR):-12.72

Loading ...

Nov 02, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Major Issues Report

8-K - Current report
Aug 01, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2022

Major Issues Report

8-K - Current report
May 31, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2022

Major Issues Report

8-K - Current report
Apr 26, 2022

Major Issues Report

8-K - Current report
Mar 18, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2022

Major Issues Report

8-K - Current report
Dec 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 01, 2021

Major Issues Report

8-K - Current report
Oct 08, 2021

Major Issues Report

8-K - Current report